Altimmune, Inc.
ALT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326190
In the last 90 days, Altimmune, Inc. insiders filed 1 open-market purchase and 0 sales; 210 institutions reported holding it in 13F filings for Q2 2026, worth $456.1M in total; Viking Global Investors is the only superinvestor holding it.
Q4 2024 vs. Q3 2024
How the institutions holding Altimmune, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 169 | 2 | 183 | +16 |
| Shares | 39.5M | 15.5K | 40.5M | +1.02M (+2.6%) |
| Value | $243.0M | $95.0K | $292.3M | +$49.5M (+20.4%) |
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (38)
Institutions that held Altimmune, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (22)
Institutions that held Altimmune, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Capital Fund Management S.A. | 726,829 | $4.46M |
| Susquehanna Portfolio Strategies, LLC | 207,197 | $1.27M |
| Portolan Capital Management, LLC | 60,976 | $374.4K |
| Alps Advisors Inc | 54,993 | $337.7K |
| ExodusPoint Capital Management, LP | 45,769 | $281.0K |
| Connor, Clark & Lunn Investment Management Ltd. | 40,705 | $249.9K |
| Campbell & CO Investment Adviser LLC | 37,426 | $229.8K |
| PVG Asset Management Corp | 23,668 | $145.3K |
| Janney Montgomery Scott LLC | 22,934 | $141.0K |
| Envestnet Asset Management Inc | 19,084 | $117.2K |
| SEI Investments Co | 12,977 | $79.7K |
| Teza Capital Management LLC | 12,346 | $75.8K |
| Independent Advisor Alliance | 10,145 | $62.3K |
| Brave Asset Management Inc | 10,000 | $61.4K |
| Acadian Asset Management LLC | 2,506 | $15.0K |
| STRS Ohio | 1,200 | $7.37K |
| NewSquare Capital LLC | 500 | $3.07K |
| Stone House Investment Management, LLC | 500 | $3.07K |
| Harbour Investments, Inc. | 310 | $1.90K |
| First Command Advisory Services, Inc. | 250 | $1.53K |
| AdvisorNet Financial, Inc | 100 | $614 |
| Capital Performance Advisors LLP | 11 | $68 |
Not filed for Q4 2024 yet (2)
Institutions that held Altimmune, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James & Associates | 15,368 | $94.4K |
| Planning Capital Management Corp | 110 | $676 |